Abrogar, Laarne .

HRN: 03-83-22  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/30/2025
06/05/2025
IV
4.5g
Q8h
Acute Pancreatitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: